Загрузка...
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...
Сохранить в:
| Опубликовано в: : | Ecancermedicalscience |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cancer Intelligence
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5102691/ https://ncbi.nlm.nih.gov/pubmed/27899953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.680 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|